Smoking cessation treatment: References​

2008 PHS Guideline Update Panel, Liaisons and Staff. (2008b). Treating Tobacco Use and Dependence: Quick Reference Guide for Clinicians – 2008 Update. Rockville, MD: Department of Health and Human Services.

Alpert, H.R., Connoly, G.N. & Biener, L. (2012). A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tobacco Control. doi: 10.1136/tobaccocontrol-2011-050129.

Bader, P., McDonald, P. & Selby, P. (2009). An algorithm for tailoring pharmacotherapy for smoking cessation: Results from a Delphi panel of international experts. Tobacco Control, 18, 34–42. doi:10.1136/tc.2008.025635.

Bohadana, A., Nilsson, F., Rasmussen, T. & Martinet, Y. (2000). Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: A randomized, double-blind, placebo-controlled trial. Archives of Internal Medicine, 160 (20), 3128–3134.

CAN-ADAPTT: The Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-Informed Tobacco Treatment. (2012). Pharmacotherapy. In Canadian Smoking Cessation Clinical Practice Guideline. Toronto: Author.

Canadian Agency for Drugs and Technologies in Health. (2014). Nicotine Replacement Therapy for Smoking Cessation or Reduction: A Review of the Clinical Evidence. Ottawa, ON: Author.

Ebbert, J.O., Hughes, J.R., West, R.J., Rennard, S.I., Russ, C., McRae, T.D. et al. (2015). Effect of varenicline on smoking cessation through smoking reduction: A randomized clinical trial. JAMA, 313 (7), 687–694. doi:10.1001/jama.2015.280.

Food and Drug Administration (U.S.). (2015, March 9). FDA drug safety communication: FDA updates label for stop smoking drug Chantix (varenicline) to include potential alcohol interaction, rare risk of seizures, and studies of side effects on mood, behavior, or thinking.

Gray, J. (Ed.). (2007). Therapeutic Choices (5th ed.). Ottawa, ON: Canadian Pharmacists Association.

Jorenby, D.E., Leischow, S.J., Nides, M.A., Rennard, S.I., Johnston, J.A., Hughes, A.R. et al. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340 (9), 685–691.

Murray, R.P., Connett, J.E. & Zapawa, L.M. (2009). Does nicotine replacement therapy cause cancer? Evidence from the Lung Health study. Nicotine and Tobacco Research, 11, 1076–1082.

Prochazka, A.V., Weaver, M.J., Keller, R.T., Fryer, G.E., Licari, P.A. & Lofaso, D. (1998). A randomized trial of nortriptyline for smoking cessation. Archives of Internal Medicine, 158 (18), 2035–2039.

Ranney, L., Melvin, C., Lux, L., McClain, E. & Lohr, K.N. (2006). Systematic review: Smoking cessation intervention strategies for adults and adults in special populations. Annals of Internal Medicine, 145 (11), 845–856.

Reid, J.L., Hammond, D., Rynard, V.L. & Burkhalter, R. (2014). Tobacco Use in Canada: Patterns and Trends, 2014 Edition. Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo.